Tag: dom3

JC: The BASICS trial. 0.9% saline vs balanced solution. Does it matter?

I’ll admit that my long term clinical practice has been to prefer balanced solutions (in my case Hartmans) over 0.9% saline in the management of the critically ill patient. It’s a topic we’ve blogged and

JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s

Back in March we reported on a pre-print trial of thromboprophylaxis of ICU patients. The results suggested that there was no benefit for therapeutic dose anticoagulation in COVID19 as a prophylactic strategy for critically ill patients with COVID19. This

targeted temperature management

JC: The TTM2 trial. Normothermia or hypothermia post cardiac arrest.

A quick update on an TTM2 trial published in the NEJM last month. As part of the chain of survival it’s important to optimise the post resuscitation phase, primarily to preserve neurological function as this

REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s

We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last month the RECOVERY trial has

Thunderstorm Asthma

Thunderstorm Asthma: St Emlyn’s

In the UK this weekend there are warnings out regarding Thunderstorm Asthma. This is a rare but well described phenomena when patients who are previously known to be grass pollen allergic (e.g. hayfever) suffer asthma

JC: Aspirin is not effective for hospitalised COVID19 patients. St Emlyn’s

We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. This week the RECOVERY trial has released the

March 2021 Podcast Round Up (episode 187). St Emlyn’s

A discussion about all the latest from the St Emlyn’s blog, including a hot off the press article about vaccine induced thrombocytopenic thrombosis and the new FRCEM revision guide.  Simon and Iain also talk about the latest results from

VITT

Post-vaccine headache in the Emergency Department: what you need to know. St Emlyn’s

I am sure you all saw the recent MHRA press release and guidance, discussing the issue of a possible link between the AstraZeneca COVID19 vaccine and a rare type of thrombotic condition of Vaccine induced

#FOAMed quality

Assessing on-line medical education resources. A podcast with Peter Brindley

Last year I was contacted by Peter Brindley, Leon Byker and Brent Thoma to collaborate on a paper for the Journal of the Intensive Care Society. The aim was to help people understand a little

thromboprophylaxis

JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s

The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for these patients as it was

MMU banner 1